CIK 0001123494
- Non-accelerated filer
- Smaller reporting company
HARVARD BIOSCIENCE INC
Sign in to watch- Ticker
- HBIO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043306140
- Phone
- +1 508-893-8999
- Business address
- 84 OCTOBER HILL RD, HOLLISTON, MA, 01746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-12 | Gagnon Robert E. Chief Financial Officer | Sale | −9,145 | $5.25 | $48K | 383,512 |
| 2018-07-12 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −5,828 | 40,000 | ||
| 2018-07-11 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +62,100 | $4.31 | $268K | 473,957 |
| 2018-07-11 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +54,172 | $4.12 | $223K | 528,129 |
| 2018-07-11 | Gagnon Robert E. Chief Financial Officer | Sale | −141,300 | $5.23 | $739K | 386,829 |
| 2018-07-11 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · stock option (right to buy) | −62,100 | 60,000 | ||
| 2018-07-11 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −54,172 | 45,828 | ||
| 2018-07-11 | Duchemin Jeffrey Chief Executive Officer | Sale | −14,205 | $5.22 | $74K | 790,742 |
| 2018-07-10 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +13,700 | $4.31 | $59K | 425,557 |
| 2018-07-10 | Gagnon Robert E. Chief Financial Officer | Sale | −13,700 | $5.38 | $74K | 411,857 |
| 2018-07-10 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −13,700 | 122,100 | ||
| 2018-07-10 | Duchemin Jeffrey Chief Executive Officer | Sale | −11,600 | $5.38 | $62K | 804,947 |
| 2018-07-09 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +14,200 | $4.31 | $61K | 426,057 |
| 2018-07-09 | Gagnon Robert E. Chief Financial Officer | Sale | −14,200 | $5.41 | $77K | 411,857 |
| 2018-07-09 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion · Stock option (right to buy) | −14,200 | 135,800 | ||
| 2018-07-09 | Duchemin Jeffrey Chief Executive Officer | Sale | −14,195 | $5.41 | $77K | 816,547 |
| 2018-06-01 | KENNEDY JOHN F Director | Grant or award | +2,400 | 310,480 | ||
| 2018-06-01 | Loewald Thomas W Director | Grant or award | +1,600 | 33,400 | ||
| 2018-06-01 | Eade Katherine A. Director | Grant or award | +1,200 | 32,700 | ||
| 2018-05-24 | Loewald Thomas W Director | Grant or award | +18,100 | 31,800 |
Page 16 of 17 · 324 trades